Division of Female Pelvic Medicine and Reconstructive Surgery, Departments of Urology & Obstetrics/Gynecology, Loyola University Medical Center, Maywood, Illinois.
Department of Microbiology and Immunology, Loyola University Chicago, Maywood, Illinois.
J Urol. 2021 Nov;206(5):1212-1221. doi: 10.1097/JU.0000000000001949. Epub 2021 Jun 29.
We compared urinary tract infection (UTI) symptom resolution rates at 7-10 days in symptomatic women randomized to treatment based on standard urine culture (SUC) versus expanded quantitative urine culture (EQUC) results.
Women ≥18 years old who responded "yes" to "do you feel you have a UTI?" agreed to urethral catheterization and followup. Symptoms were assessed using the validated UTI Symptom Assessment (UTISA) questionnaire. Culture method was randomized 2:1 (SUC:EQUC); antibiotics were prescribed to women with positive cultures. The primary outcome, UTI symptom resolution, was determined 7-10 days following enrollment on all participants regardless of treatment.
Demographic data were similar between groups. Of the SUC and EQUC groups 63% and 74% had positive cultures (p=0.10), respectively. Of participants with positive cultures 97% received antibiotics. Primary outcome data were provided by 215 of 225 participants (SUC 143 [95%], EQUC 72 [97%]). At the primary outcome assessment, 64% and 69% in the SUC and EQUC groups, respectively, reported UTI symptom resolution (p=0.46); UTISA scores improved from baseline in the EQUC arm compared to the SUC arm (p=0.04). In the subset of women predominated by non- (76), there was a trend toward more symptom resolution in the EQUC arm (21%, p=0.08).
Symptom resolution was similar for the overall population ( and non-) of women treated for UTI symptoms based on SUC or EQUC. Although the sample size limits conclusions regarding the utility of EQUC in women with non- uropathogens, the detected trend indicates that this understudied clinical subset warrants further study.
我们比较了根据标准尿液培养(SUC)与扩展定量尿液培养(EQUC)结果随机分组进行治疗的有症状女性在 7-10 天尿路感染(UTI)症状缓解率。
对回答“是否感到患有 UTI?”为“是”的年龄≥18 岁女性进行尿道导管插入术并进行随访。使用经过验证的 UTI 症状评估(UTISA)问卷评估症状。培养方法随机分为 2:1(SUC:EQUC);对阳性培养的女性开具抗生素。所有参与者无论接受何种治疗,均在入组后 7-10 天根据主要结局(UTI 症状缓解)进行评估。
两组的人口统计学数据相似。SUC 和 EQUC 组分别有 63%和 74%的培养阳性(p=0.10)。阳性培养的参与者中,97%接受了抗生素治疗。225 名参与者中有 215 名(SUC 143[95%],EQUC 72[97%])提供了主要结局数据。在主要结局评估时,SUC 和 EQUC 组分别有 64%和 69%的患者报告 UTI 症状缓解(p=0.46);与 SUC 组相比,EQUC 组的 UTISA 评分从基线开始改善(p=0.04)。在以非(76)为主的女性亚组中,EQUC 组的症状缓解趋势更为明显(21%,p=0.08)。
根据 SUC 或 EQUC 治疗 UTI 症状的女性总体人群(和非)的症状缓解情况相似。尽管样本量限制了 EQUC 在非尿路感染病原体女性中的实用性结论,但检测到的趋势表明,这一研究不足的临床亚组值得进一步研究。